Foster Victor Wealth Advisors 13F: Adds $1.3M to ISRG Stake

Foster Victor Wealth Advisors lifted its stake in Intuitive Surgical, Inc. (NasdaqGS: ISRG) during the third quarter, according to a Form 13F filing with the SEC on October 21, 2026. The firm purchased an additional 2,915 shares, representing a 14.7% increase from its previous holding. The firm ended the period with 22,749 shares of the medical equipment maker, with the total position valued at approximately $9,854,613. ISRG shares closed at $428.12 on the filing date. ## What Changed in Foster Victor Wealth Advisors's Intuitive Surgical Position

The investment firm expanded its footprint in the healthcare provider by growing its share count from 19,834 up to 22,749 shares. This 2,915-share increase brought the reported value of the stake to nearly $9.85 million. ## Other Institutional Activity in Intuitive Surgical

Other large investors also adjusted their positions in the medical technology company during the reporting period. Assenagon Asset Management S.A. grew its holdings by 558,099 shares, ending with 1,557,940 shares worth about $633,505,142. Meanwhile, Davenport reduced its holdings by 145,132 shares, leaving it with 8,095 shares valued at approximately $3,291,545.

ISRG Intuitive Surgical, Inc.

$428.12 ▼ -23.82% year to date

1M 3M YTD

Daily close · Oct 21, 2026

Intuitive Surgical, Inc. Stock Down 0.8%

Intuitive Surgical shares recently traded around $434.42 as of October 22, 2026, which is up about 1.5% from the filing day close. The stock changes hands well above its 50-day moving average of $394.19 and sits roughly 0.7% below its 200-day moving average of $437.66. Over the past year, the shares have moved between a low of $328.57 and a high of $603.88.

Recent Earnings

For the trailing twelve months, the company generated $11,580,000,384 in revenue and reported earnings of $8.27 per share. The business achieved a net profit margin of 25.5% and a return on equity of 17.9%. The next quarterly earnings report is scheduled for January 21, 2027.

Insider Buying and Selling at Intuitive Surgical, Inc.

Company insiders completed several share transactions in late summer. Officer Mark Preston Brosius sold 154 shares on August 21, 2026, followed by 69 shares on September 9, 2026, and 48 shares on September 11, 2026. Additionally, officer Fredrik Widman sold 1,089 shares at $374.44 per share on September 15, 2026, for a total value of $407,765.

Analysts Set New Price Targets

Wall Street firms updated their views on the stock on October 21, 2026. Leerink Partners maintained an Outperform rating and raised its target from $473.00 to $503.00. JP Morgan maintained an Overweight rating while lifting its target from $450.00 to $475.00. Evercore ISI Group maintained an In-Line rating while lowering its target from $400.00 to $385.00. Wells Fargo maintained an Overweight rating with a target of $486.00, down slightly from $487.00, and TD Cowen reiterated a Buy rating with a target of $485.00. The stock holds a consensus buy rating and a mean price target of $480.17 across thirty analyst opinions.

About Intuitive Surgical

Headquartered in Sunnyvale, California, Intuitive Surgical, Inc. designs and builds robotic-assisted surgical systems and related instruments. Its da Vinci surgical systems allow doctors to perform complex procedures through tiny incisions, improving patient access to minimally invasive care worldwide. The firm employs over 17,000 people to support hospitals and surgical teams globally.

Bottom Line

Institutional interest in Intuitive Surgical remains active as the company heads toward its next financial update in January 2027. Investors will continue tracking adoption rates for robotic surgical systems alongside broader market trends and analyst revisions.